Illuminant Surgical

Illuminant Surgical

Private
Culver City, CaliforniaHealthcare & Life Scienceshttps://www.illuminant.ai

Last Round

Seed

Apr 30, 2026

Total Funding Raised

$9.47M

Momentum Score

75 /100

Company Overview

Illuminant Surgical is a medical technology company that develops surgical navigation systems. Its main product, Skylight™, is a platform that uses artificial intelligence, computer vision, and dynamic projection mapping to display anatomical images from medical scans directly onto a patient's skin in real-time. This technology aims to provide surgeons with 'x-ray vision' without the need for headsets or external monitors, thereby improving precision and workflow efficiency during procedures. The company is initially focusing on applications in spine surgery, pain management, and interventional radiology. Founded in 2021 by Stanford alumni Eldrick Millares and Dr. James Hu, Illuminant Surgical is a graduate of the Y Combinator accelerator program and has received grant funding from the National Science Foundation. The company is headquartered in Culver City, California.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Computer Vision, Medical Imaging, AR/VR Experiences

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Government Contracts

AI Layer

Application

Keywords

surgical navigationaugmented reality surgeryimage-guided surgeryprojection mappingsurgical ARsurgical computer visionanatomical projectionsurgical guidancesurgical AImedical deviceMedTechspine surgery navigationpatient registrationinterventional radiology guidancefiducial markers

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Illuminant Surgical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Illuminant Surgical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedApr 30, 2026
GrantSep 15, 2024
GrantJan 8, 2024
SeedSep 7, 2022

Key People

Founding team and executive leadership

James Hu

Co-Founder, Co-Chief Executive Officer

Founding Team

Illuminant Surgical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 30, 2026

    $8.4M round led by Wing 2 Wing Ventures

  • Nov 4, 2025

    Presenting at the 2025 MDIC MedXR Summit in November.

Illuminant Surgical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Illuminant Surgical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Illuminant Surgical's valuation, stock price, and market status.

Firmographic Details

HeadquartersCulver City, California
Employee Range21
Year Founded2021
Last FundingApr 30, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.